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Objective. To establish whether different criteria to assess severity of aortic stenosis (AS)  may 
have additive prognostic relevance in asymptomatic patients with normal left ventricular function. 
Design. Retrospective study.  
Setting. Outpatient echocardiographic laboratories. 
Patients. One-hundred forty-nine AS patients  (74.5±9.4 years, 52% males), with at least one of 
the following 4 criteria: peak aortic flow velocity (Vmax) >4m/sec; mean transvalvular gradient 
(MG)>40 mm Hg; aortic valve area (AVA) <1 cm
2
; AVA indexed for body surface area (AVAI) <0.6 
cm
2
/m
2
.  Mean follow-up duration was 25.9±22.3 months.  
Main outcome measures. Combination of all-cause death or aortic valve replacement (AVR).  
Results. Outcome was better in the 69 patients (46%) with ≤2 criteria,  than in the 80 patients with 
≥3 criteria (p<0.001); and in patients with neither MG>40 mm Hg nor Vmax >4 m/sec compared 
with those having at least one of these 2 criteria (p<0.001). At univariate Cox survival analysis,  
MG>40 mmHg and/or Vmax >4m/sec were the best predictors for the combined end-point. At 
multivariate analysis, predictors of outcome were male gender (HR 1.751 CI 95% 1.111-2.758, 
p=0.016), higher MG (HR per 10 mmHg increase 2.626, CI95% 1.663-4.146), p<0.001) and active 
smoking (HR 3.84 CI 95% 1.15-12.8, p=0.028). In patients with MG≤40 mmHg, an AVAI <0.4 
cm2/m2  provided further risk stratification (4-year event-free survival 33%, vs. 58% in patients 
>0.4 cm2/m2 (p=0.001).  
Conclusions. Hierarchical prognostic assessment of AS severity favors MG>40 mmHg as the most 
potent predictors of outcome. However, the convergence of multiple criteria adds predictive 
accuracy , supporting the need for multiparametric assessment of hemodynamics in asymptomatic 
patients with severe AS.   
Word count: 250 
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Doppler echocardiography plays a pivotal role in non-invasive hemodynamic assessment of 
aortic stenosis (AS). Among multiple available measures, peak aortic flow velocity (Vmax), mean 
transvalvular gradient (MG) and effective aortic valve area, either simple (AVA) or indexed for 
body surface area (AVAI), are recommended for the  assessment of the severity of AS. In 
particular, Vmax >4m/sec,  MG>40 mm Hg,  AVA <1 cm
2  
and AVAI<0.6 cm
2
/m
2
 have all been 
suggested as cutoffs indicating severe AS. [1-3] However, it has been recently shown that these 
parameters are not interchangeable, resulting into inconsistent estimates of the prevalence of 
severe AS, with potential implication for clinical follow-up and decision making.[4-6] Furthermore, 
while each of these criteria has been utilized for defining AS severity, their relative accuracy in 
predicting outcome is unresolved.  
The apparent discrepancies in AS severity measures might be clinically relevant  both in 
symptomatic and asymptomatic individuals. In symptomatic patients, inconsistencies among  
different echocardiographic parameters may lead to misinterpretation of symptoms and 
subsequent inappropriate delay of aortic valve replacement (AVR). In asymptomatic patients, such 
discrepancies can result in inappropriate follow-up strategies and hinder appropriate 
management. This is particularly relevant in elderly individuals, in whom interpretation of 
symptoms and management decisions are complicated further by multiple, age-related problems 
associated with AS.[7-9]  
In order to resolve these challenging issues, we therefore chose to assess outcome in 
asymptomatic AS patients with normal left ventricular (LV) ejection fraction and at least one 
echocardiographic criterion for severe AS. The aim of the study was to evaluate whether different 
criteria have variable prognostic relevance in these patients, and whether the presence of  
multiple  criteria might hold incremental value in predicting outcome. 
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METHODS   
Patient Population. We enrolled subjects with a diagnosis of AS aged ≥21 years, 
consecutively studied at outpatient echocardiographic laboratories, having at least one of the 
following 4 criteria: Vmax >4m/sec; MG>40 mm Hg; AVA <1 cm
2
; AVAI<0.6 cm
2
/m
2
. Exclusion 
criteria were: any symptom attributable to AS;  left ventricular (LV) ejection fraction <50%;  the 
presence of additional valvular disease more than mild in severity;  the presence of congenital 
heart disease except bicuspid aortic valve; previous valvular or aortic surgery,  primary 
hypertrophic or restrictive cardiomyopathy;  neoplastic disease or significant co-morbidity of 
potential prognostic impact.  
Echocardiographic and Doppler Measurements. Echocardiography was performed with 
commercially available ultrasound systems. All patients underwent a comprehensive examination 
including M-mode and two-dimensional echocardiography, with continuous wave, pulsed and 
color Doppler,  by experienced operators.  For each measurement, three cardiac cycles were 
averaged. In all patients the LV end-diastolic and end-systolic volumes (indexed for body surface 
area) were measured using the biplane Simpson’s rule method, from which the LV ejection 
fraction was calculated.[10] The LV mass (in grams) was calculated using the Devereux formula 
and then indexed for body surface area. Relative wall thickness was computed as 2x posterior wall 
thickness/LV radius at end-diastole.[10] 
The LV outflow tract diameter was measured in mid-systole from the parasternal long-axis 
view below the aortic valve. Pulsed-wave Doppler sampling of the LV outflow tract was performed 
below the aortic valve at the point where the flow velocity dropped when moving the sample 
volume from the aortic valve level into the outflow tract, matching the location of LV outflow tract 
diameter measurement. Maximum velocity and velocity time integral were measured by tracing 
the modal velocity (middle of the dense signal) for use in the continuity equation and calculation 
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of stroke volume using an optimal signal . Transvalvular velocities were interrogated by 
continuous-wave Doppler (including a non-imaging transducer) from multiple windows to obtain 
Vmax.  Maximal instantaneous gradient across the aortic valve was calculated using a modified 
Bernoulli equation;  MG was measured by tracing of the velocity curve. AVA was calculated by the 
continuity equation [3] and indexed for body surface area (AVAI). Calcification of the aortic valve 
was qualitatively assessed and classified as previously suggested.[3] Arterial blood pressure was 
measured at the right arm by a trained nurse, using a properly sized cuff sphygmomanometer.  
Follow-up and Endpoints. Follow-up information was obtained from office visits or direct 
interviews with the patients, their relatives or their general practitioner. The endpoint was a 
composite of all-cause mortality and AVR. Mean follow-up duration was 26±22 months (range 4-
122 months) and was completed in all study patients.  
Particular attention was given to the information regarding indications for AVR and cause 
of death, so that the reports from in-hospital stay and death certifications were obtained in all 
patients and carefully examined. The primary indications for AVR were classified as (a) 
development of AS-related symptoms, (b)  patients with severe AS who developed LV ejection 
fraction <50%; (c) patients with severe AS undergoing coronary artery bypass graft surgery; and (d) 
patients with severe AS undergoing surgery on the aorta. Causes of death was ascertained by the 
review of reports from in-hospital stay and death certifications. 
Statistical methods.  Continuous variables are expressed as mean±SD unless otherwise 
specified. Unpaired Student’s t-test or one-way analysis of variance were employed for 
comparison of normally distributed data. Chi-square or Fisher’s exact test, as appropriate, were 
utilized to compare noncontinuous variables expressed as proportions.  Survival curves were 
constructed according to the Kaplan-Meier method, and comparisons were performed using the 
log-rank test. Hazard ratios and 95% confidence intervals were calculated using univariate and 
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multivariate Cox proportional hazard regression models. Multivariate analyses were performed 
with a stepwise forward regression model, by which only variables with a p-value of ≤0.05 (based 
on univariate analysis) were entered into the model; variables included age, gender, 
hypercholesterolemia, diabetes mellitus, arterial hypertension, coronary artery disease (defined as 
previous acute coronary syndrome and/or revascularization procedures, or positive stress tests of 
inducible ischemia, or any coronary artery stenosis >70% at coronary angiography), LV ejection 
fraction, LV mass index, Vmax, MG, AVA, AVAI.  All P-values are two-sided and considered 
significant when <0.05. Calculations were performed using a SPSS 12.0 software (Chicago, IL).  
RESULTS 
Baseline patient features. The study group consisted of 149 patients whose main clinical 
and echocardiographic characteristics are shown in Table 1 . 
 
Table 1: Baseline characteristics of study patients. Data are reported as mean ± SD (range) unless 
otherwise specified.  
Variable Patients 
(n=149) 
CLINICAL DATA  
Age (Years) 74.5±9.4 (40-94) 
Male (n;%) 78 (52%) 
Height (m) 1.66±0.1 (1.45-1.9) 
Weight (kg) 74±13 (46-110) 
Body surface area (m
2
) 1.80±0.2 (1.2-2.28) 
Body mass index (kg/m
2
) 26.7±4.1 (16.5-40.4) 
Systolic Blood Pressure (mmHg) 142±16 (105-185) 
Diastolic Blood pressure (mmHg) 79.5±9.5 (50-110) 
Arterial hypertension (n;%) 115 (77%) 
Diabetes (n;%) 25 (16.8%) 
Hypercholesterolemia (n;%) 57 (38%) 
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Coronary artery disease 24 (16%) 
Current Smoking (n;%) 7 (4.6%) 
ECHOCARDIOGRAPHIC DATA  
Left Ventricular end-diastolic diameter (mm) 50.1±5(37-64) 
Inter-ventricular septal thickness (mm) 12.9±1.6 (8-18) 
Posterior wall thickness (mm) 11.9±1.4 (8-17) 
Left ventricular mass (g) 252.9±61 (135-458) 
Left ventricular mass index (g/m
2
) 141.1±35.3 (80-238) 
Relative wall thickness  0.51±0.39 (0.3-0.76) 
Left ventricular end-diastolic volume index (ml/m
2
) 66±12 (40-90) 
Left-ventricular ejection fraction(%) 61.2±5 (50-78) 
Stroke volume index (ml/m
2
) 44.1±9.6 (26,6-70 
Peak aortic velocity (m/sec) 4.08±0.64 (2.6-6.8) 
Mean aortic gradient (mmHg) 41.6±15.5 (13-115) 
Aortic valve area (cm
2
) 0.88±0.20 (0.45-1.5) 
Indexed aortic valve area (cm
2
/m
2
) 0.45±0.62 (0.16-0.8) 
 
Aortic valve calcification was severe in all subjects. Most patients (111; 74%) were >70 
years.  AVAI was <0.6 cm
2
/m
2
 in 142 ( 95%); 104 patients (70%) had AVA<1 cm
2
, 82 (55%) Vmax 
>4m/sec, and 77 (52%) MG>40 mmHg. MG was directly related to Vmax (R
2
=0.79, beta 0.89, 
p<0.001) and inversely to AVA (R
2
=0.29, beta -0.54, p<0.001).  AVAI was only moderately  related 
to AVA (R
2
=0.28, beta 0.53, p<0.001), Vmax (R
2
=0.18, beta -0.43, p<0.001) and MG (R
2
=0.12, beta -
0.35, p<0.001). LV stroke volume indexed for body surface area was higher in patients with MG>40 
mmHg (46.7±9.2 ml/m
2
) than in patients with MG<40 mm Hg (40.9±9 ml/m
2
 ; p<0.001) and was 
below normal limits (<35 ml/m
2
 ) in 22 patients (14.7%).  
 Outcome. During follow-up (26±22 months, range 4-122 months), a total of 86 patients 
(58%) either died (n=31;20%) or had AVR (n=55;37%). Survival  was 95% at 1 year, 84% at 2 years, 
76% at 3 years, 70% at 4 years;  survival free  of the combined end-point of all-cause mortality and 
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AVR  was 84% at 1 year, 61% at 2 years, 46% at 3 years and 36% at 4 years. AVR was advised due 
to progression of  symptoms in 48 patients or decline of LV ejection fraction (<50%) in 2, rapid 
progression of AS in 3 patients, and triggered by need for coronary artery revascularization in 2. 
The cause of death was of definite cardiovascular origin in 24 patients (including 2 ischemic 
strokes), of non-cardiac origin in 5 (including 1 with perioperative mortality at noncardiac surgery), 
and could not be determined in the remaining 2. Event-free survival at 4 years was not different in 
patients with stroke volume index < or ≥35 ml/m
2
 (32% vs 37%, respectively, p=0.78) . 
Relevance of multiparametric evaluation of AS to outcome. Event- free survival was 
significantly better in the 69 patients (46%) with ≤2 positive criteria for severe AS,  compared with 
the remaining 80 patients who had ≥3 criteria (p<0.001) (Figure 1). There was a clear, additive 
trend towards a worse prognosis based on the number of positive criteria. In particular, survival 
was better for AS patients who had neither MG>40 mmHg nor Vmax >4 m/sec compared with those 
who had at least one of these 2 criteria [58% (SE 8%) vs 19% (SE 11%) at 4 years]. Moreover, in 73 
patients (49%)  with MG≤40 mmHg, an AVAI <0.4 cm
2
/m
2
 (i.e.: the median value for AVAI) was 
associated with a 4 year event-free survival of  33% compared to 58% (P=0.001) (Figure 2).  
At  univariate Cox survival analysis,  MG>40 mm Hg,  Vmax >4m/sec or their combination 
showed the best predictive capability for the combined end-point (Figure 3). At multivariate Cox 
survival analysis, the three independent predictors of outcome were male gender (HR 1.75, CI 95% 
1.11-2.76; p=0.016), increased MG (HR per 10 mmHg increase 2.62, CI95% 1.66-4.15; p<0.001) and 
active smoking (HR 3.84, CI 95% 1.15-12.8; p=0.028). Predictors did not change after excluding the 
5 patients without primary indication to AVR (data not shown). Of note, patients with ≥3 variables, 
compared to those with ≤2, had an almost 3-fold increase in likelihood for the combined end-point 
(HR  2.88, CI 95% 1.68-4,94; p<0.001).  
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DISCUSSION  
Management of severe AS in the absence of symptoms is controversial and challenging [1-
3, 5, 11-13]. Because of the natural history of severe asymptomatic AS, accurate 
echocardiographic grading is crucial for clinical decision making. Nevertheless, echocardiographic 
methods employed to this purpose have shown limitations in predicting symptom onset and 
outcome. Specifically, the relative predictive accuracy of the most commonly used parameters 
used to define severe AS (i.e.: Vmax >4m/sec, or MG>40 mm Hg, or AVA <1 cm
2
, or AVAI<0.6 
cm
2
/m
2
) is unresolved. As a novel contribution we thus planned to assess the value of 
multiparametric echocardiographic evaluation in asymptomatic AS patients with ≥1 criterion for 
severe AS and normal LV ejection fraction. Our findings show that (i) Vmax >4 m/sec and MG>40 
mm Hg predicted the combined end-point of death or AVR more effectively than the area-related 
criteria, with MG>40 mm Hg resulting as the only independent echocardiographic predictor at 
multivariable analysis; (ii) the positivity for multiple criteria had a significant additive effect 
compared to any single criterion alone, in predicting  worse event-free survival; and that (iii) in 
patients with MG≤40 mm Hg , an extreme narrowing of AVAI< 0.4 cm
2
/m
2 
provided increasing 
predictive value.    
Increasing Vmax has been related to the natural history of AS in multiple studies, over a 
broad range of values ranging from mild to very severe increase in aortic peak velocity. [12-16]   
Consistently, rate of progression of AS severity in terms of yearly changes in Vmax, is prognostically 
relevant in asymptomatic patients with any grade of AS severity, both from  referral centers and 
outpatient facilities.[3,5,9]  Due to the strict relation between Vmax and MG, the prognostic 
superiority over area-related parameters is similar for Vmax and MG in the present study. However, 
because obstruction related to AS persists throughout the systolic ejection period, the relationship 
between Vmax and mean gradient depends on the shape of the velocity curve, which varies with 
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stenosis severity and flow rate. [3] Thus, since MG is assessed from multiple mean instantaneous 
calculations around the whole continuous-wave Doppler envelope, it retains informations of the 
waveform shape, and it is likely more representative of the severity of AS than Vmax. [17, 18] Thus, 
MG c nstitutes the optimal indicator of severity of obstruction by retaining all these information, 
and is more reliably related to invasive hemodynamics than peak aortic gradient [3,6, 17-20].  
Conversely, conflicting results have been reported regarding the prognostic significance of 
AVA. Some recent studies, in fact, have demonstrated that AVA is not necessarily related to 
mortality [11, 15,16]. These results, however, could have been at least partially biased by referral 
criteria segmenting a priori subsets of AS patients enrolled in tertiary center studies. Indeed, a 
recent community study including AS patients without life-threatening comorbid conditions, with 
any degree of AS severity, and a wide range of clinical presentations, demonstrated AVA<1 cm
2
 to 
be the only measure of  AS severity independently predictive of survival on medical treatment. 
[21]  Since AVA is related to cardiac output and therefore to body size [22], the correction for body 
surface area has been proposed in the early 1960’s, with the advantage that indexing AVA for 
body surface area provides a measure of severity of aortic valve narrowing which also 
incorporates stroke volume index. A value of AVAI<0.7 cm
2
/m
2
 is generally proposed as a cut-off 
for severe AS .[23] Intriguingly, a similar AVAI value of ≤0.6 cm
2
/m
2
 has been shown to correlate 
with a LV stroke work loss of ≥30%.[24] Recently, in 103 consecutive, asymptomatic patients with 
AVA <1 cm
2  
 and a small average body surface area (1.50±0.15 m
2
), AVAI <0.6 cm
2
/m
2
 was shown 
to be a significant predictor of outcome.[25]  
For each value of AVA, different situations can be detected in terms of transaortic flow 
rates and pressure gradients, giving rise to a discordance between gradients and AVA. While such 
discrepancies might represent an inherent inconsistency of the criteria present in most guidelines, 
or reflect small body size or measurement errors  [4,6] an increasing body of evidence now 
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supports the entity of low gradient severe AS with paradoxical low-flow (i.e.: reduced stroke 
volume index with normal ejection fraction) whose natural history seems to be comparable to 
severe narrowing of the AVA coexisting with high flow and high gradient.[11,26-29] Indeed, we 
observed  no differences in outcome  in our patients with low or normal stroke volume index.  
The findings of the present study may have several implications for the hierarchical use of 
primary hemodynamic parameters recommended for assessment of risk associated with severe 
AS. The independent accuracy of MG>40 mm Hg underscores the need for accurate velocity 
recording from multiple acoustic windows,  in order to optimize the assessment of aortic 
velocities, which remains the more robust and reproducible measurement in daily practice. 
Moreover, convergence of more measures should be interpreted as a further increase in 
predictive capability, with practical influences on follow-up and decision making. In patients  with 
MG≤40 mmHg,  who were characterized by lower stroke volume index, the same hierarchical 
approach can be proposed to identify those at greater risk. Indeed, further stratification of these 
patients based on an AVAI threshold of 0.4cm
2
/m
2
 provided a clinically meaningful predictor of the 
combined end-point, consistent with a recently proposed classification of severe asymptomatic 
AS. [11] 
Irrespective of the  parameter utilized for its assessment, our findings confirm that the 
prognosis of severe, asymptomatic AS is dismal.[15,16,30]   Thus, it is important not to 
underestimate the hemodynamic severity of AS in patients with less than expected MG or Vmax . 
[25-30] Maximal care should be paid in assessing each of the components of the continuity 
equation, particularly as regards consistency of LV stroke volume as assessed by Doppler with that 
assessed by evaluation of LV ejection fraction, but also to optimize hemodynamic systemic 
conditions know to potentially affect AVA (i.e.: systemic arterial hypertension). Furthermore, in 
selected patients, additional diagnostic tools (such as magnetic resonance, computed tomography 
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or cardiac catheterization) should be taken in consideration for proper assessment of severity. 
[28,30] 
This study has several limitations. Although the baseline data were prospectively collected 
in consecutive patients with AS referred to the echocardiographic laboratory,  the outcome data 
were retrospectively obtained. Moreover, we did not assess the rate of hemodynamic progression 
of AS in our patients, which have been shown to be an independent determinant of outcome in 
multiple clinical setting. Similarly, symptomatic status was not objectively assessed.. Future 
prospective studies are warranted to assess the value of multiparametric assessment in AS in the 
light of disease progression and n objective evaluation of functional capacity. 
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FIGURE LEGENDS 
Figure 1: Kaplan-Meier event-free (overall-mortality and AVR) survival for patients with one or two 
criteria (n=69) and patients with three or four criteria (n=80). 
Figure 2: Kaplan-Meier event-free (overall-mortality and AVR) survival for patients with MG > 40 
mmHg and ≤40 mmHg with AVAI < or ≥0.4cm
2
/m
2
.   
Figure 3: Univariate Cox regression analysis for the combined end-point (overall mortality and 
AVR) for each parameter and their combination (Hazard Ratio ± 95% confidence interval). 
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